| Year |
Citation |
Score |
| 2019 |
Sharma A, Grill MF, Spritzer S, Leis AA, Anderson M, Vig P, Porter AB. Malignant Glial Neuronal Tumors After West Nile Virus Neuroinvasive Disease: A Coincidence or a Clue? The Neurohospitalist. 9: 160-164. PMID 31244973 DOI: 10.1177/1941874418819621 |
0.316 |
|
| 2014 |
Hearst SM, Shao Q, Lopez M, Raucher D, Vig PJ. Focused cerebellar laser light induced hyperthermia improves symptoms and pathology of polyglutamine disease SCA1 in a mouse model. Cerebellum (London, England). 13: 596-606. PMID 24930030 DOI: 10.1007/S12311-014-0576-1 |
0.719 |
|
| 2014 |
Hearst SM, Shao Q, Lopez M, Raucher D, Vig PJ. The design and delivery of a PKA inhibitory polypeptide to treat SCA1. Journal of Neurochemistry. 131: 101-14. PMID 24903464 DOI: 10.1111/Jnc.12782 |
0.731 |
|
| 2014 |
Vig PJ, Hearst SM, Shao Q, Lopez ME. Knockdown of acid-sensing ion channel 1a (ASIC1a) suppresses disease phenotype in SCA1 mouse model. Cerebellum (London, England). 13: 479-90. PMID 24788087 DOI: 10.1007/s12311-014-0563-6 |
0.735 |
|
| 2012 |
Vig PJ, Wei J, Shao Q, Lopez ME, Halperin R, Gerber J. Suppression of calbindin-D28k expression exacerbates SCA1 phenotype in a disease mouse model. Cerebellum (London, England). 11: 718-32. PMID 22076800 DOI: 10.1007/s12311-011-0323-9 |
0.476 |
|
| 2012 |
Hearst S, Lopez M, Shao Q, Vig P. D2R Agonist Bromocriptine Improves Neurodegeneration in Spinocerebellar Ataxia Type 1 Mouse Model (P05.021) Neurology. 78: P05.021-P05.021. DOI: 10.1212/Wnl.78.1_Meetingabstracts.P05.021 |
0.741 |
|
| 2011 |
Hearst SM, Walker LR, Shao Q, Lopez M, Raucher D, Vig PJ. The design and delivery of a thermally responsive peptide to inhibit S100B-mediated neurodegeneration. Neuroscience. 197: 369-80. PMID 21958864 DOI: 10.1016/J.Neuroscience.2011.09.025 |
0.724 |
|
| 2011 |
Vig PJ, Hearst S, Shao Q, Lopez ME, Murphy HA, Safaya E. Glial S100B protein modulates mutant ataxin-1 aggregation and toxicity: TRTK12 peptide, a potential candidate for SCA1 therapy. Cerebellum (London, England). 10: 254-66. PMID 21384195 DOI: 10.1007/S12311-011-0262-5 |
0.756 |
|
| 2010 |
Hearst SM, Lopez ME, Shao Q, Liu Y, Vig PJ. Dopamine D2 receptor signaling modulates mutant ataxin-1 S776 phosphorylation and aggregation. Journal of Neurochemistry. 114: 706-16. PMID 20477910 DOI: 10.1111/j.1471-4159.2010.06791.x |
0.737 |
|
| 2009 |
Vig PJ, Shao Q, Subramony SH, Lopez ME, Safaya E. Bergmann glial S100B activates myo-inositol monophosphatase 1 and Co-localizes to purkinje cell vacuoles in SCA1 transgenic mice. Cerebellum (London, England). 8: 231-44. PMID 19593677 DOI: 10.1007/s12311-009-0125-5 |
0.479 |
|
| 2006 |
Vig PJ, Lopez ME, Wei J, D'Souza DR, Subramony S, Henegar J, Fratkin JD. Glial S100B Positive Vacuoles In Purkinje Cells: Earliest Morphological Abnormality In SCA1 Transgenic Mice. Journal of Neurological Sciences (Turkish). 23: 166-174. PMID 18176630 DOI: 10.1901/Jaba.2006.23-166 |
0.391 |
|
| 2005 |
Mizutani A, Wang L, Rajan H, Vig PJ, Alaynick WA, Thaler JP, Tsai CC. Boat, an AXH domain protein, suppresses the cytotoxicity of mutant ataxin-1. The Embo Journal. 24: 3339-51. PMID 16121196 DOI: 10.1038/Sj.Emboj.7600785 |
0.329 |
|
| 1998 |
Vig PJ, Subramony SH, Burright EN, Fratkin JD, McDaniel DO, Desaiah D, Qin Z. Reduced immunoreactivity to calcium-binding proteins in Purkinje cells precedes onset of ataxia in spinocerebellar ataxia-1 transgenic mice. Neurology. 50: 106-13. PMID 9443466 DOI: 10.1212/Wnl.50.1.106 |
0.338 |
|
| 1997 |
Paulson HL, Perez MK, Trottier Y, Trojanowski JQ, Subramony SH, Das SS, Vig P, Mandel JL, Fischbeck KH, Pittman RN. Intranuclear inclusions of expanded polyglutamine protein in spinocerebellar ataxia type 3. Neuron. 19: 333-44. PMID 9292723 DOI: 10.1016/S0896-6273(00)80943-5 |
0.443 |
|
| Show low-probability matches. |